Market Research Industry Today

Cattle Biologics Manufacturing Market - Global Industry Analysis Trends And Forecast 2014 - 2020

A new Upcoming market report by Transparency Market Research is Cattle Biologics Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
Published 30 September 2015

Cattle biologics are defined as the vaccines, bacterins, diagnostics etc which helps to prevent, diagnose or treat the disease conditions in cattle and calves. These product works through some immunological pathway. The cattle biologics manufacturing market consist of four major segments on the basis of the products namely:

  • Vaccines 
  • Pre-breeding vaccines for calves
  • Antibodies
  • Diagnostic kits

Get Our Expert Opinion in detail Report:

Among these categories, vaccines and pre-breeding vaccines for calves capture the major share of the market. Vaccines are provided to both cattle and calves, especially the new born calves to save them from various diseases such as clostridial diseases, anthrax, bovine virus diarrhea and vibriosis. On the basis of type of manufacturing the cattle biologics manufacturing market is divided into four main categories which include:

  • Bacterins
  • Bacterin Toxoid
  • Non-bacterins
  • Custom made Vaccines

Bacterins include vaccines which are made from killed bacteria, while the bacterin toxoids include vaccines which are made from live bacteria. In cattle vaccination, bacterin toxoid is preferred over other vaccination due to its long lasting effect. Texas Vet Lab, Inc. is one of the major market players of bacterins and bacterin toxoid and it is offering a wide range of products in its portfolio such as moraxella ovis, unique serovars of Salmonella and Histophilus Somni. Custom-made vaccines are also capturing a major part of the cattle biologics manufacturing market and have been complement to “off-the-shell” products in the U.S. market. Custom-made vaccines are the vaccines which are manufactured from the specific virus or bacteria which is major cause of disease in livestock operation. Newport Laboratories is one of the market players which is offering custom-made vaccines to the producers and veterinarians which gives them option to prepare a mixture of different products, modified according to producer that is not commercially available. 

Pre-breeding vaccination includes the vaccines, which are given to calves at the age between 12 months to 15 months. These vaccines are provided to calves to protect them against common reproductive diseases. On the basis of the vaccines which are provided to the calves, cattle biologics manufacturing market is divided into six major classes:

  • Bovine Viral Diarrhea (BVD)
  • Infectious Bovine Rhinotracheitis (IBR)
  • Leptospirosis
  • Bovine respiratory syncytial virus (BRSV)
  • Clostridium
  • Trichomoniasis

Among these the bovine viral diarrhea is most commonly used vaccine followed by leptospirosis and trichomoniasis. All these pre-breeding vaccinations protect calves from delayed breeding, smaller calves, potential abortions and persistently infected calves. 

Request For Brochure:

North America and Europe currently lead the cattle biologics manufacturing market majorly due to strong economic conditions and large number of cattle population. The major market of Europe is driven by Switzerland, which is known for cows and cattle. In 2010, there were 1,591, 233 cattle in Switzerland. Additionally, the government of U.S. and Europe has also setup some regulatory firms which are also helping the market to grow. As in Canada, the Canadian Food Inspection Agency (CFIA) regulates veterinary biologics and animal health products such as antibody products, vaccines, diagnostic kits that are used for the prevention, treatment and diagnosis of infectious diseases in animals. Other major market players in cattle biologics market include Addison Cattle Corporation, Agrilabs, Biocor Animal Health, Inc., Boehringer Ingelheim, Colorado Serum Company, Durvet, Inc., Fort Dodge Animal Health, Merial, Novartis AG and Pfizer, Inc.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  

This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Mr. Nachiket
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453


Other Industry News

Ready to start publishing

Sign Up today!